1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA COX4I2 CTRPv2 pan-cancer AAC -0.1 0.001
mRNA KIAA1456 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ZFYVE21 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA SLBP CTRPv2 pan-cancer AAC 0.11 0.001
mRNA KCNA2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SCRT2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MED30 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA S100PBP CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CCDC126 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA MRPS18B CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV